静脉血栓和肥胖:从临床需求到治疗挑战
Federica La Rosa1, Fabrizio Montecucco2,3, Luca Liberale1,4
1First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 Viale Benedetto XV, 16132, Genoa, Italy.
Internal and emergency medicine
|September 13, 2024
概括
肥胖症显著增加了由于慢性炎症和代谢变化的静脉血栓栓塞 (VTE) 的风险. 为了有效预防和治疗肥胖患者的VTE,需要更多的研究.
科学领域:
- 心血管医学 心血管医学
- 代谢障碍 代谢障碍 代谢障碍
- 血液学 血液学 血液学
背景情况:
- 肥胖越来越被认为是各种病理状况 (包括心血管疾病) 的重要危险因素.
- 静脉血栓栓塞 (VTE) 是第三个最常见的心血管疾病,与肥胖有着关键的联系.
- 体重偏差在历史上限制了对肥胖的系统健康后果的理解.
研究的目的:
- 审查肥胖和静脉血栓塞栓症 (VTE) 之间的复杂关系.
- 要突出潜在的机制,如脂肪病变和免疫血栓形成,这增加了肥胖的VTE风险.
- 确定目前VTE风险评估,预防和治疗肥胖患者的缺陷.
主要方法:
- 关于肥胖和VTE的现有研究的文献综述.
- 对将肥胖与高凝血性和内皮功能障碍联系起来的病理生理机制的分析.
- 检查当前临床指导方针和有关肥胖人群VTE管理的证据.
主要成果:
- 肥胖是由脂肪病引起的,通过慢性炎症,高凝固性和内皮功能障碍促进了前血栓状况.
- 免疫血栓,炎症诱导的血块形成,进一步提高了肥胖患者的静脉瘤风险.
- 在准确评估VTE风险以及在肥胖患者当前抗凝血剂预防和治疗的有效性方面存在重大差距.
结论:
- 肥胖是VTE的主要多因素风险,需要深入了解简单的风险因素.
- 量身定制的治疗策略和强大的临床试验对于解决患有肥胖症的人群VTE预防和管理的独特挑战至关重要.
- 创新研究对于改善结果和减少越来越多受肥胖影响的人群中VTE负担至关重要.
更多相关视频
相关概念视频
Esophageal Varices-II: Clinical Features and Management
51
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
51
Obesity
411
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
411
Venous Return
3.3K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
3.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
652
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
652
Esophageal Varices-I: Introduction
90
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
90
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K


